BlackRock to add bitcoin as eligible investment to two funds

David Randall
·2 min read
FILE PHOTO: A sign for BlackRock Inc hangs above their building in New York

By David Randall

(Reuters) - BlackRock Inc, the world's largest asset manager, is adding bitcoin futures as an eligible investment to two funds, a company filing showed.

The company said it could use bitcoin derivatives for its funds BlackRock Strategic Income Opportunities and BlackRock Global Allocation Fund Inc.

The funds will invest only in cash-settled bitcoin futures traded on commodity exchanges registered with the Commodity Futures Trading Commission, the company said in a filing to the Securities and Exchange Commission on Wednesday.

A BlackRock representative declined to comment beyond the filings when contacted by Reuters.

Earlier this month, Bitcoin, the world's most popular cryptocurrency, hit a record high of $40,000, rallying more than 900% from a low in March and having only just breached $20,000 in mid-December.

Bitcoin tumbled 10.6% in midday U.S. trading Thursday.

Other U.S.-based asset managers will likely follow BlackRock's lead and add exposure to bitcoin in some form to their go-anywhere or macro strategies as the cryptocurrency market becomes more liquid and developed, said Todd Rosenbluth, director of mutual fund research at CFRA.

"It’s easy to see how strong the performance has been of late and look at a historical asset allocation strategy that would have included a slice of crypto and how returns would have been enhanced as a result," he said. "Large institutional investors are going to be able to tap into the futures market in a way that a retail investor could not do."

There is currently no U.S.-based exchange-traded fund that owns bitcoin, limiting the ability of most fund managers to own the cryptocurrency in their portfolios.

BlackRock Chief Executive Officer Larry Fink had said at the Council of Foreign Relations in December that bitcoin is seeing giant moves every day and could possibly evolve into a global market. (https://bit.ly/2XXFHrB)

(Reporting by David Randall; Additional reporting by Radhika Anilkumar and Bhargav Acharya in Bengaluru; Editing by Arun Koyyur and Lisa Shumaker)

Latest Stories

  • Mark Hamill Reveals The Star Wars Meme That Makes Him 'Cringe Every Time'

    Hamill shared the image and an explanation.

  • Gloucestershire meteorite is first UK find in 30 years

    Fragments are recovered from the blazing fireball that lit up the sky above England last month.

  • Assembly Election 2021 LIVE Updates: Assam breaks all record in poll seizures, items worth Rs 18 crore caught so far

    Assembly Election 2021 LIVE Updates: Officials have arrested 100 for their involvement in selling illegal liquor and eight have been held for narcotics-related crimes since MCC kicked in

  • Uttarakhand CM to Meet Governor Amid Crisis: What We Know So Far

    Amid reports of change of guard in Uttarakhand, CM Trivendra Singh Rawat is scheduled to meet the Governor at 4 pm.

  • Katie Couric becomes first female 'Jeopardy!' host on International Women’s Day

    Viewers were elated to see Couric hosting and making history on International Women's Day.

  • Digitization and Advanced Analytics Power the Global Security Industry

    The aim of this study is to deliver a comprehensive analysis of the global security industry and to uncover insights for global security leaders, businesses, and governments. The report provides detailed market sizing and forecasting from the year 2020 to 2030 with a sectorial view on three verticals that are divided into subcategories based on application areas:1.New York, March 09, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Digitization and Advanced Analytics Power the Global Security Industry" - https://www.reportlinker.com/p06033750/?utm_source=GNW Critical National Infrastructure (CNI): prisons, government estates, judiciary, oil & gas, utilities (power and water)2. Public Safety: safe cities, BFSI, law enforcement, disaster management, large-scale events, mass transportation (rail, bus, and metro)3. Border Security: airports, maritime ports, land bordersRead the full report: https://www.reportlinker.com/p06033750/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

  • World IT Market Leaders Benchmark Report 2021 - When and Why Vendors Win

    Dublin, March 09, 2021 (GLOBE NEWSWIRE) -- The "Competitive Market Leaders - When and Why Vendors Win" report has been added to ResearchAndMarkets.com's offering. The goal of this report is to provide the retail community with the most detailed and complete picture imaginable of the retail technology landscape. It aims to assist retailers in vendor selection and to help the industry understand the trends, drivers and barriers that are fundamentally transforming our industry. Who is really winning among IT Vendors? Are retailers really shunning Amazon Web Services (AWS)? Who are customers increasing business within 2021? Does that differ by segment? How are solution provider's customers performing? Which vendors have customers best positioned for 2021? Who is getting the largest deal sizes in 2021? This is just some of the data that is included in this research. This is what they said who is winning their business and why. This is a ranking of vendors, but it's not a popularity contest. This was one additional question in a survey of 300 major brands about who they were increasing business with, decreasing business with, don't do business with, or won't do business with. The result is a series of rankings. Rankings include the following: Amazon (AWS), Aptos, Blue Yonder, CDW, Cisco, Dell, Fujitsu, GK Software, HP Inc., IBM, Infor, JDA, Manhattan Assoc., Microsoft, NCR, Oracle, SalesForce, SAP, Shopify, Toshiba GCS, Sensormatic Retail and Zebra. Retailers are encouraged to use these charts in discussions with their vendor partners. It is the intent that they provide unique insights into vendor strategy and provide thought-provoking questions as we all move through and prosper in the Era of Intentional Innovation. Key Topics Covered: OverviewTop Vendors Increasing Market Share in 2021 - OverallTop Average Deal Leaders for 2021 - OverallTop Vendors Increasing Market Share in Food/Drug/Mass Merchants/C-Stores 2021Top Vendors Increasing Market Share in GMS for 2021Rank for Average Deal Size in Food/Drug/Mass Merchants/C-Stores 2021Rank for Average Deal Size in GMS for 2021Who are Winning Retailers Increasing Business Within 2021Average Deal Size in Winning RetailersVendor's Whose Customers Are Growing the Fastest?Vendors Whose Customers Are Increasing Profits Fastest?Vendor Rank Based on Customer Sales Increase Expectations for 2021Vendor Rank Based on Customer Profit Expectations for 2021Rank by 2021 Customer Expected Sales GrowthRank by 2021 Customer Expected Digital Order GrowthRank by 2021 Customer Expected Digital Orders for Store FulfillmentRank by Vendor for Total Store Fulfillment of Orders in 2021 Companies Mentioned Amazon (AWS)AptosBlue YonderCDWCiscoDellFujitsuGK SoftwareHP Inc.IBMInforJDAManhattan Assoc.MicrosoftNCROracleSalesForceSAPShopifyToshiba GCSSensormatic RetailZebra For more information about this report visit https://www.researchandmarkets.com/r/5csgho CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

  • UPDATE 1-Russia's Sputnik V could be made in Europe for first time after Italy deal signed

    Russia's Sputnik V vaccine against COVID-19 could be produced in Europe for the first time after a commercial deal to produce it in Italy was signed by the Moscow-based RDIF sovereign wealth fund and Swiss-based pharmaceutical company Adienne. The agreement, which will need approval from Italian regulators before production can be launched, has been confirmed by both RDIF and the Italian-Russian chamber of commerce.

  • India’s Vaccine Leadership to Help World Overcome COVID: Gopinath

    Gopinath said Indian vaccine production & growth projection will play an important role in overcoming the pandemic.

  • 16 factors that will impact Bengal elections

    Mamata is the best CM candidate for 54% of the respondents in a C-Voter survey.

  • Iceland Seafood International hf: Annual General Meeting 18 March 2021- Final Proposals and Agenda

    The Annual General Meeting of Iceland Seafood International hf will be held on Thursday 18 March 2021 at 4pm at Hilton Reykjavík Nordica, Suðurlandsbraut 2, 108 Reykjavik, Iceland. The meeting will be webcasted live, a link will be published on the Company's website www.icelandseafood.com/investors before the meeting starts. Recording will also be available after the meeting on the Company's website. Enclosed is the final agenda for the Annual General Meeting 2021 and final proposals. No changes have been made neither to the proposals nor the agenda since the meeting was convened. Information and documents for the Annual General Meeting can be found on the company's website: http://www.icelandseafood.com/Press/Annual-General-Meeting-18-March-2021 Attachments ISI_AGM_Board Proposals 2021 - Final ISI_AGM_Notice to convene the AGM 2021 - Final

  • Good Morning, Britain: Meghan Markle Didn’t Spill the Tea, She Smashed the China

    There are some things you just don’t do on British television, and slamming the Royal Family tops the list. But in the course of two momentous hours, an unwritten, invisible code of conduct that quietly permeates most Royal-centric programming in the U.K. came crashing down. “Oprah with Meghan and Harry: A Primetime Special” aired on […]

  • Piers Morgan storms off Good Morning Britain after Alex Beresford condemns him for ‘trashing’ Meghan Markle

    Beresford described Morgan’s behaviour as ‘pathetic’ and ‘diabolical’

  • Partial, Semi-autonomous Driving and EU General Safety Regulation Set to Propel Global Driver Monitoring System Market

    Driver distraction and drowsiness are major causes of road traffic crashes worldwide. A review for the European Commission found driver distraction to be the likely factor in 10% to 30% of road collisions in Europe each year.New York, March 09, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Partial, Semi-autonomous Driving and EU General Safety Regulation Set to Propel Global Driver Monitoring System Market" - https://www.reportlinker.com/p06033751/?utm_source=GNW Driver monitoring systems (DMS) can address this critical challenge by monitoring driver drowsiness and attention. The introduction of partial and semi-autonomous-driving vehicles accentuates the need for such monitoring features. Recent regulatory mandates in the European Union and increased attention in North America owing to accidents involving vehicles with partial driving automation are driving the DMS markets in these regions.However, these rapid developments, the COVID-19 pandemic, and cost concerns pose market challenges, impeding DMS penetration. In this study on DMS markets in Europe and North America, The analyst highlights the regulatory, technological, and competitive landscapes in these markets. The report also covers DMS market analyses, including business models, product strategies, and growth opportunities, for both regions with forecasts until 2030.Read the full report: https://www.reportlinker.com/p06033751/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

  • Notice to Convene the Annual General Meeting of Genmab A/S

    Company Announcement Genmab A/S to hold wholly virtual Annual General Meeting on April 13, 2021 COPENHAGEN, Denmark; March 9, 2021 – Genmab A/S (Nasdaq: GMAB) summons the Annual General Meeting on Tuesday, April 13, 2021 at 14:00 PM CET. Due to the COVID-19 pandemic the annual general meeting will be held as a wholly virtual general meeting without physical attendance in accordance with the Danish Executive Order no. 2240 of December 29, 2020. The notice for the Annual General Meeting, including Appendix 1: Candidates for the Board of Directors and Appendix 2: Proposed amended Remuneration Policy is attached. About Genmab Genmab is an international biotechnology company with a core purpose to improve the lives of patients with cancer. Founded in 1999, Genmab is the creator of multiple approved antibody therapeutics that are marketed by its partners. The company aims to create, develop and commercialize differentiated therapies by leveraging next-generation antibody technologies, expertise in antibody biology, translational research and data sciences and strategic partnerships. To create novel therapies, Genmab utilizes its next-generation antibody technologies, which are the result of its collaborative company culture and a deep passion for innovation. Genmab’s proprietary pipeline consists of modified antibody candidates, including bispecific T-cell engagers and next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. The company is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan. For more information, please visit Genmab.com. Contact: Marisol Peron, Senior Vice President, Global Investor Relations & CommunicationsT: +1 609 524 0065; E: mmp@genmab.com For Investor Relations: Andrew Carlsen, Senior Director, Head of Investor RelationsT: +45 3377 9558; E: acn@genmab.com This Company Announcement contains forward looking statements. The words “believe”, “expect”, “anticipate”, “intend” and “plan” and similar expressions identify forward looking statements. Actual results or performance may differ materially from any future results or performance expressed or implied by such statements. The important factors that could cause our actual results or performance to differ materially include, among others, risks associated with pre-clinical and clinical development of products, uncertainties related to the outcome and conduct of clinical trials including unforeseen safety issues, uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of protection of our patents and proprietary rights, our relationships with affiliated entities, changes and developments in technology which may render our products or technologies obsolete, and other factors. For a further discussion of these risks, please refer to the risk management sections in Genmab’s most recent financial reports, which are available on www.genmab.com and the risk factors included in Genmab’s most recent Annual Report on Form 20-F and other filings with the U.S. Securities and Exchange Commission (SEC), which are available at www.sec.gov. Genmab does not undertake any obligation to update or revise forward looking statements in this Company Announcement nor to confirm such statements to reflect subsequent events or circumstances after the date made or in relation to actual results, unless required by law. Genmab A/S and/or its subsidiaries own the following trademarks: Genmab®; the Y-shaped Genmab logo®; Genmab in combination with the Y-shaped Genmab logo®; HuMax®; DuoBody®; DuoBody in combination with the DuoBody logo®; HexaBody®; HexaBody in combination with the HexaBody logo®; DuoHexaBody®; HexElect®; and UniBody®. Arzerra® and Kesimpta® are trademarks of Novartis AG or its affiliates. DARZALEX® and DARZALEX FASPRO® are trademarks of Janssen Pharmaceutica NV. TEPEZZA® is a trademark of Horizon Therapeutics plc. Company Announcement no. 20CVR no. 2102 3884LEI Code 529900MTJPDPE4MHJ122 Genmab A/SKalvebod Brygge 431560 Copenhagen VDenmark Attachment 210309_CA20_AGM Calling_Final

  • Best wedding guest dresses: The stylish wedding guest dresses and outfits to shop now

    Banish your RSVP woes

  • New crackdown on Extinction Rebellion and Black Lives Matter needed due to ‘huge inconvenience’, minister says

    Fresh requirements to notify the police and cut noise - while restricting demonstrations at Parliament

  • ITV To Hold Talks With Piers Morgan After He Cast Doubt On Meghan Markle’s Suicidal Thoughts

    ITV CEO Carolyn McCall has said that the UK broadcaster will hold talks with Piers Morgan after the Good Morning Britain presenter said live on-air that he did not believe Meghan Markle had suicidal thoughts. McCall was asked about Morgan’s behavior several times during a media call for ITV’s 2020 earnings today, and the former […]

  • ITV 2020 profit dives but BritBox sign-ups surge

    Due to the lack of video-on-demand drivers, such as Love Island, fewer soaps and no major sporting events, online viewing was down 5%, the broadcaster said.

  • Massive Machine Type Communication in the Healthcare Market - Emergence of 5G Complementing Healthcare IoT

    Dublin, March 09, 2021 (GLOBE NEWSWIRE) -- The "Massive Machine Type Communication in Healthcare Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering. The Massive Machine Type Communication in Healthcare Market is expected to grow at a CAGR of 7.34% over the forecast period (2021-2026). With the rapid penetration of advanced technology and embedded devices, healthcare is undergoing an expeditious transformation toward a distributed, patient-centric approach, accommodating the need for faster, accurate, and real-time response solutions.Healthcare devices are currently running on existing technologies, such as Wi-Fi, Bluetooth, and low-power technologies, but as the market matures, the need for connectivity to various devices will fuel the growth of massive machine type communication. Today, the healthcare segment faces numerous challenges such as infrastructure, connectivity, optimal resource, need for a specialist, data management, and real-time monitoring, driving the technological applications to fill the considerable gap. As per close examination of the worldwide statistics with available data for 2005-2015, indicated that around 40% of countries have less than one physician per 1000 population and less than 18 hospital beds per 10,000 population, driving the growth of the market. The emerging 5G network is anticipated to support smart healthcare applications that can fulfill most of the requirements, such as ultra-low latency, high bandwidth, ultra-high reliability, high density, and high energy efficiency. The advent of 5G is expected to support smart healthcare by faster and precise communication between machines and devices. Key Market TrendsWireless Machine Holds the Dominant Position in the Massive Machine Type Communication in Healthcare MarketHealth condition monitoring is particularly important in chronic conditions hence, continuous monitoring and recording of signals through wearable provides a realistic view of the patient's health condition. Low power wearable also prevents patients daily visit to the clinical center for regular checkups and enable to track blood pressure, pulse rates, temperature, and HRR, etc. In the future, devices are expected to be connected to the wireless ecosystem and will transmit data automatically to the application server, via the M2M network, and enable the doctors to track the patient's health conditions remotely.Wireless transmission through the devices improves the patient's mobility and provides an opportunity to monitor outside the health organizations. It will also act as a lifesaver by monitoring the patient's condition in real-time and in case of an emergency the information from sensors can be communicated to the nearby hospitals.North America holds the Dominant Position in the Massive Machine Type Communication in Healthcare MarketNorth America is expected to be the highest revenue contributor to the market, by 2025, due to an increase in the health-conscious customer base and investments in R&D of technologies and devices, to remotely provide expert medical treatment.Next-generation 5G systems that are designed to provide wireless connectivity for massive machine-type communications (mMTC) and to support ultra-reliable, low latency communication (URLLC) are also driving the market in North America. Many hospitals are investing on equipment's and technologies to improve clinical outcomes and enhance patient safety. For instance, Saratoga Hospital in Saratoga Springs, New York, is ultilizing Philips' IntelliVue Guardian Solution patient monitoring technology, and has reduced 63% of the cases being transferred to the intensive care units.Competitive LandscapeThe massive machine type communication in healthcare market consists of several major players and is moderately competitive. Few of the major players currently dominate the market, in terms of market share. The market is moderately fragmented and there is a high level of competition. These major players, with prominent shares in the market, are focusing on expanding the customer base across foreign countries, through strategic alliances.Key Topics Covered: 1 Introduction2 Research Methodology3 Executive Summary4 Market Insights5 Market Dynamics5.1 Market Drivers5.1.1 Augmented Demand for a Better Healthcare Connectivity Experience5.1.2 Emergence of 5G Complementing Healthcare IoT5.2 Market Challenges5.2.1 Huge Initial Capital Investment Involved in Developing 5G Infrastructure5.2.2 Security and Privacy of Patient's Data5.3 Industry Value Chain Analysis6 Market Segmentation6.1 By Communication Channel Type6.2 By Application (Qualitative Trend Analysis)6.2.1 Equipment Management6.2.2 Remote Monitoring6.2.3 Medical diagnostic6.2.4 Others Applications6.3 By Region7 Competitive Landscape Telefonaktiebolaget LM EricssonNokia CorporationCisco Systems Inc.Panasonic CorporationKoninklijke Philips NVHuawei Technologies Co. LtdTelecom Italia (TIM SpA)Qualcomm IncorporatedIntel Corporation 8 Investment Analysis9 Future of The MarketFor more information about this report visit https://www.researchandmarkets.com/r/vd25w About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900